Symbols

NEO

Neogenomics·NASDAQ

--(--)

6.46 / 10

Outperform

Sentiment scores 6.46 (Outperform) and fund‑flow 7.48 (good), yet trends are negative across all investor sizes. Analysts are split: one Strong Buy, one Buy, yielding an average rating of 4.5 while the stock fell 12.7%. Mixed outlook.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

50%

Buy

50%

Hold

Sell

Strong Sell

Date2026-02-24

InstitutionPiper Sandler

Times predicted3

Historical Win Rate33.3%

Is money flowing into or out of NEO?

NEO holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.46/10 (Outperform).